Ş. KÖSE, "New Direct Acting Antivirals Fort the Treatment of Chronic Hepatitis C in Patients With End Stage Renal Disease Population," APASL 2017 , 2017
KÖSE, Ş. 2017. New Direct Acting Antivirals Fort the Treatment of Chronic Hepatitis C in Patients With End Stage Renal Disease Population. APASL 2017 .
KÖSE, Ş., (2017). New Direct Acting Antivirals Fort the Treatment of Chronic Hepatitis C in Patients With End Stage Renal Disease Population . APASL 2017
KÖSE, ŞÜKRAN. "New Direct Acting Antivirals Fort the Treatment of Chronic Hepatitis C in Patients With End Stage Renal Disease Population," APASL 2017, 2017
KÖSE, ŞÜKRAN. "New Direct Acting Antivirals Fort the Treatment of Chronic Hepatitis C in Patients With End Stage Renal Disease Population." APASL 2017 , 2017
KÖSE, Ş. (2017) . "New Direct Acting Antivirals Fort the Treatment of Chronic Hepatitis C in Patients With End Stage Renal Disease Population." APASL 2017 .
@conferencepaper{conferencepaper, author={ŞÜKRAN KÖSE}, title={New Direct Acting Antivirals Fort the Treatment of Chronic Hepatitis C in Patients With End Stage Renal Disease Population}, congress name={APASL 2017}, city={}, country={}, year={2017}}